1.Stomato-facial morbidity structure in the pathological anatomy during 1998-1999
Journal of Vietnamese Medicine 1999;232(1):37-38
Classification of disease structure to compare between clinical and histological diagnosis were daily works of histological department. We have met a need recurrent diagnosis of diseases in stomato- facial area. It has meaningful in statistics, treatment, study and training
Stomatognathic Diseases
;
Pathological Conditions, Anatomical
2.Some pathological anatomic features of testicular cancer
Journal of Medical and Pharmaceutical Information 2003;10():35-38
It’s very important to identify pathological anatomic features in the treatment and prognosis of testicular cancer. In this study, 112 patients who were diagnosed by clinical and paraclinical symptoms were classified according to age, location, and severity. Their samples then were stained by PSA test. Results: 49% were germ cell tumors of scrotum, 9% were none germ cell tumors, and 42% were dystopic germ cell tumors. Base on pathological anatomic features (stage, location) we can apply different methods of treatment to gain better outcomes
Testicular Neoplasms
;
Pathological Conditions, Anatomical
;
Prognosis
;
diagnosis
3.To evaluate the recovering threshold of the pathological mast blastocyte in the case of serum beta-hCG < 5 IU/l.
Journal of Practical Medicine 2003;454(6):2-5
Blastomeres; Serum; Pathological Conditions, Anatomical; Chorionic Gonadotropin
The group 1 of 75 cases of post molar evacuation and the group 2 of 292 cases of gestational trophoblastic tumors (GTT) were followed up until beta-hCG level serum, determined by IMX, reaches the threshold of < 5 IU/l, there was not any complication after 2 years. There were 7.5% recurrents cases in GTT group, in some cases, beta-hCG reaches 0 UI/l. In the recurrent group, the rate of resistance to the treatment got to 40%, and the rate of resistance to single chemotherapy by MTX got to 30%. 50% of recurrent patients have had uterine histological exams with 36% choriocarcinoma, 4.5% invasive molar
Blastomeres
;
Serum
;
Pathological Conditions, Anatomical
;
Chorionic Gonadotropin